Implanet SA Total Assets
Implanet SA total assets. Based on the latest financial reports, Implanet SA (ALIMP) holds total assets worth €18.45 Million EUR (≈ $21.57 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Implanet SA market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Implanet SA (2010–2025)
Total assets of Implanet SA from 2010 to 2025. This chart illustrates how Implanet SA's total assets have evolved over time, based on quarterly financial data. See ALIMP live share price for real-time trading data and today's change.
Implanet SA - Asset Composition Analysis
Implanet SA Total Assets Breakdown (December 2025)
Implanet SA total assets breakdown as of December 2025. Implanet SA's total assets of €18.45 Million consist of 74.5% current assets and 25.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 16.3% |
| Accounts Receivable | €3.21 Million | 17.4% |
| Inventory | €7.01 Million | 38.0% |
| Property, Plant & Equipment | €2.02 Million | 11.0% |
| Intangible Assets | €2.58 Million | 14.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Implanet SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Implanet SA short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Implanet SA's current assets represent 74.5% of total assets in 2025, an increase from 0.0% in 2010.
- Cash Position: Cash and equivalents constituted 16.3% of total assets in 2025, up from 9.2% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 13.0% of total assets, an increase from 0.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 38.0% of total assets.
Implanet SA Competitors by Total Assets
Key competitors of Implanet SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085
|
China | CN¥2.34 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
PULSION Medical Systems SE
MU:PUS
|
Germany | €35.15 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Memphasys Ltd
AU:MEM
|
Australia | AU$10.45 Million |
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
Implanet SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.80 | 0.85 | 1.50 |
| Quick Ratio | 0.39 | 0.38 | 0.74 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-3.46 Million | €-1.89 Million | €2.33 Million |
Implanet SA - Advanced Valuation Insights
This section examines the relationship between Implanet SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 65.50 |
| Latest Market Cap to Assets Ratio | 1.22 |
| Asset Growth Rate (YoY) | 23.9% |
| Total Assets | €18.45 Million |
| Market Capitalization | $22.50 Million USD |
Valuation Analysis
Above Book Valuation: The market values Implanet SA's assets above their book value (1.22x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Implanet SA's assets grew by 23.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Implanet SA (2010–2025)
The table below shows the annual total assets of Implanet SA from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €18.45 Million ≈ $21.57 Million |
+23.89% |
| 2024-12-31 | €14.89 Million ≈ $17.41 Million |
+39.98% |
| 2023-12-31 | €10.64 Million ≈ $12.44 Million |
-26.51% |
| 2022-12-31 | €14.47 Million ≈ $16.92 Million |
-13.34% |
| 2021-12-31 | €16.70 Million ≈ $19.53 Million |
+91.96% |
| 2020-12-31 | €8.70 Million ≈ $10.17 Million |
-9.82% |
| 2019-12-31 | €9.65 Million ≈ $11.28 Million |
+9.04% |
| 2018-12-31 | €8.85 Million ≈ $10.35 Million |
-29.56% |
| 2017-12-31 | €12.56 Million ≈ $14.69 Million |
-23.67% |
| 2016-12-31 | €16.46 Million ≈ $19.24 Million |
+1.03% |
| 2015-12-31 | €16.29 Million ≈ $19.04 Million |
+11.92% |
| 2014-12-31 | €14.55 Million ≈ $17.02 Million |
-39.16% |
| 2013-12-31 | €23.92 Million ≈ $27.97 Million |
+103.23% |
| 2012-12-31 | €11.77 Million ≈ $13.76 Million |
-29.58% |
| 2011-12-31 | €16.72 Million ≈ $19.54 Million |
+42.02% |
| 2010-12-31 | €11.77 Million ≈ $13.76 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more